Clinical Trials Browser

Unknown × INDUSTRY × ponatinib × Clear all

NCT03709017 2022-12-07

Iclusig PMS in CML or Ph+ALL Patients

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive